1.4(top 50%)
impact factor
3.9K(top 5%)
papers
58.7K(top 5%)
citations
99(top 5%)
h-index
1.4(top 50%)
extended IF
4.8K
all documents
62.9K
doc citations
154(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1The Subgenual Anterior Cingulate Cortex in Mood DisordersCNS Spectrums2008954
2Mild Cognitive Impairment:An OverviewCNS Spectrums2008561
3Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side EffectsCNS Spectrums2005447
4SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of AntidepressantsCNS Spectrums2005410
5New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivityCNS Spectrums2014408
6Functional Neuroimaging Studies of Human EmotionsCNS Spectrums2004405
7Freeze, Flight, Fight, Fright, Faint: Adaptationist Perspectives on the Acute Stress Response SpectrumCNS Spectrums2004388
8Mechanism of Action of Trazodone:a Multifunctional DrugCNS Spectrums2009373
9Food and Drug Administration RegulationCNS Spectrums2008362
10The Prevalence of Body Dysmorphic Disorder in the United States Adult PopulationCNS Spectrums2008347
11The neurobiology of aggression and violenceCNS Spectrums2015328
12The Neurobiology of Substance and Behavioral AddictionsCNS Spectrums2006314
13The Precuneus and ConsciousnessCNS Spectrums2007304
14Hot and cold cognition in depressionCNS Spectrums2013298
15The role of reproductive hormones in postpartum depressionCNS Spectrums2015284
16Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorderCNS Spectrums2015273
17State of the science on mild cognitive impairment (MCI)CNS Spectrums2019269
18Inflammation, Glutamate, and Glia in Depression:A Literature ReviewCNS Spectrums2008265
19Beyond Monoamines: Glutamatergic Function in Mood DisordersCNS Spectrums2005258
20Long-Term, Open-Label Extension Study of Guanfacine Extended Release in Children and Adolescents with ADHDCNS Spectrums2008258
21Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to AntidepressantsCNS Spectrums2009257
22Conceptually Driven Pharmacologic Approaches to Acute TraumaCNS Spectrums2005239
23Potential Markers for Problematic Internet Use: A Telephone Survey of 2,513 AdultsCNS Spectrums2006239
24The Interplay of Neurotransmitters in Alzheimer's DiseaseCNS Spectrums2005233
25Psychiatric Comorbidity of Internet Addiction in College Students: An Interview StudyCNS Spectrums2008232
26Selective Histamine H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of AntihistaminesCNS Spectrums2008231
27A Virtual Reality Scenario for All Seasons:The Virtual ClassroomCNS Spectrums2009222
28Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypesCNS Spectrums2017220
29Mechanism of action of pimavanserin in Parkinson’s disease psychosis: targeting serotonin 5HT2A and 5HT2C receptorsCNS Spectrums2016213
30Risk of Recurrence of Depression During Long-Term Antidepressant TreatmentCNS Spectrums2007211
31The Role of Glutamate in Anxiety and Related DisordersCNS Spectrums2005203
32Abuse and Neglect in Childhood: Relationship to Personality Disorder DiagnosesCNS Spectrums2003198
33Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New DataCNS Spectrums2005197
34Forgotten but not gone: new developments in the understanding and treatment of tardive dyskinesiaCNS Spectrums2016196
35Converting oral to long-acting injectable antipsychotics: a guide for the perplexedCNS Spectrums2017194
36Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic propertiesCNS Spectrums2014192
37Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamateCNS Spectrums2018192
38Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studiesCNS Spectrums2020182
39Psychiatric Comorbidity in 36 Adults with Mitochondrial CytopathiesCNS Spectrums2007180
40New Pharmacotherapeutic Approaches to Obsessive-Compulsive DisorderCNS Spectrums2009177
41Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patientsCNS Spectrums2014177
42Expanding the definition of addiction: DSM-5 vs. ICD-11CNS Spectrums2016176
43Defining and Diagnosing Involuntary Emotional Expression DisorderCNS Spectrums2006173
44Long-term effects of cariprazine exposure on dopamine receptor subtypesCNS Spectrums2014173
45The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the Assessment of Multiple Addictions in a High-School Population:Prevalence and Related DisabilityCNS Spectrums2006171
46Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut–brain pathwaysCNS Spectrums2016167
47Sensory Phenomena in Obsessive-Compulsive Disorder and Tic Disorders:A Review of the LiteratureCNS Spectrums2008166
48Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD:A Randomized, Controlled TrialCNS Spectrums2006162
49Keeping Up with Clinical Advances: Opioid Use DisorderCNS Spectrums2019162
50Overview of Diagnosis and Drug Treatments of Anxiety DisordersCNS Spectrums2005161